(SCM) Stellus Capital Investment - Ratings and Ratios
Debt, Equity, Mezzanine, Unitranche
Dividends
| Dividend Yield | 13.35% |
| Yield on Cost 5y | 25.85% |
| Yield CAGR 5y | 8.56% |
| Payout Consistency | 95.7% |
| Payout Ratio | 38.6% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 19.6% |
| Value at Risk 5%th | 32.6% |
| Relative Tail Risk | 1.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.17 |
| Alpha | -4.80 |
| CAGR/Max DD | 0.46 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.572 |
| Beta | 0.565 |
| Beta Downside | 0.656 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.87% |
| Mean DD | 6.71% |
| Median DD | 6.15% |
Description: SCM Stellus Capital Investment October 25, 2025
Stellus Capital Investment Corp. (NYSE: SCM) is a Business Development Company (BDC) that targets private middle-market firms in the United States and Canada, deploying first-lien, second-lien, unitranche, and mezzanine debt-often paired with equity stakes. The firm focuses on companies generating EBITDA of roughly $5 million to $50 million, positioning itself as a flexible capital provider in the lower-mid segment of the credit market.
Key industry context: (1) BDCs have benefited from a low-interest-rate environment, with average net asset yields hovering around 8-9% in 2024, but rising rates are compressing spreads on senior debt. (2) Middle-market M&A activity in North America grew ~12% YoY in Q2 2024, expanding the pool of potential acquisition-oriented borrowers. (3) Credit quality metrics for this EBITDA band show a weighted-average leverage ratio of 3.2×, indicating moderate default risk that BDCs like Stellus can manage through covenants and seniority structures.
For a deeper quantitative view, you might explore ValueRay’s platform to compare Stellus’s credit metrics against peers and assess how its capital structure choices perform under different economic scenarios.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (30.5m TTM) > 0 and > 6% of Revenue (6% = 4.17m TTM) |
| FCFTA -0.00 (>2.0%) and ΔFCFTA -2.95pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -226.1m% (prev -65.62%; Δ -226.1mpp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.00 (>3.0%) and CFO -49.3m <= Net Income 30.5m (YES >=105%, WARN >=100%) |
| Current Ratio 0.09 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (28.5m) change vs 12m ago 8.18% (target <= -2.0% for YES) |
| Gross Margin 51.67% (prev 54.04%; Δ -2.37pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 0.00% (prev 8.75%; Δ -8.75pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.68 (EBITDA TTM 32.5m / Interest Expense TTM 33.6m) >= 6 (WARN >= 3) |
Altman Z'' -1.00
| (A) -0.15 = (Total Current Assets 16170.82b - Total Current Liabilities 173163.34b) / Total Assets 1028644.34b |
| (B) -0.00 = Retained Earnings (Balance) -21.7m / Total Assets 1028644.34b |
| (C) 0.00 = EBIT TTM 56.4m / Avg Total Assets 514322.65b |
| (D) 0.00 = Book Value of Equity 28.93b / Total Liabilities 650914.01b |
| Total Rating: -1.00 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 52.27
| 1. Piotroski 2.0pt |
| 2. FCF Yield -0.00% |
| 3. FCF Margin -71.02% |
| 4. Debt/Equity 1.24 |
| 5. Debt/Ebitda data missing |
| 6. ROIC - WACC (= 5.26)% |
| 7. RoE 0.00% |
| 8. Rev. Trend 47.91% |
| 9. EPS Trend 16.42% |
What is the price of SCM shares?
Over the past week, the price has changed by +5.19%, over one month by +11.70%, over three months by -6.84% and over the past year by +5.22%.
Is SCM a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SCM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.1 | 1.1% |
| Analysts Target Price | 13.1 | 1.1% |
| ValueRay Target Price | 15.2 | 17.1% |
SCM Fundamental Data Overview December 10, 2025
P/E Trailing = 11.633
P/E Forward = 12.1359
P/S = 3.5796
P/B = 0.9664
Beta = 0.658
Revenue TTM = 69.4m USD
EBIT TTM = 56.4m USD
EBITDA TTM = 32.5m USD
Long Term Debt = 632.3m USD (from longTermDebt, last quarter)
Short Term Debt = 172522.71b USD (from shortTermDebt, last quarter)
Debt = 468328.34b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 459304.32b USD (from netDebt column, last quarter)
Enterprise Value = 468328.70b USD (367.1m + Debt 468328.34b - CCE 9.02m)
Interest Coverage Ratio = 1.68 (Ebit TTM 56.4m / Interest Expense TTM 33.6m)
FCF Yield = -0.00% (FCF TTM -49.3m / Enterprise Value 468328.70b)
FCF Margin = -71.02% (FCF TTM -49.3m / Revenue TTM 69.4m)
Net Margin = 43.96% (Net Income TTM 30.5m / Revenue TTM 69.4m)
Gross Margin = 51.67% ((Revenue TTM 69.4m - Cost of Revenue TTM 33.6m) / Revenue TTM)
Gross Margin QoQ = 48.66% (prev 56.26%)
Tobins Q-Ratio = 0.46 (Enterprise Value 468328.70b / Total Assets 1028644.34b)
Interest Expense / Debt = 0.00% (Interest Expense 8.95m / Debt 468328.34b)
Taxrate = 7.15% (515.7k / 7.21m)
NOPAT = 52.4m (EBIT 56.4m * (1 - 7.15%))
Current Ratio = 0.09 (Total Current Assets 16170.82b / Total Current Liabilities 173163.34b)
Debt / Equity = 1.24 (Debt 468328.34b / totalStockholderEquity, last quarter 377730.33b)
Debt / EBITDA = 14.1m (out of range, set to none) (Net Debt 459304.32b / EBITDA 32.5m)
Debt / FCF = -9.31m (out of range, set to none) (Net Debt 459304.32b / FCF TTM -49.3m)
Total Stockholder Equity = 94432.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.00% (Net Income 30.5m / Total Assets 1028644.34b)
RoE = 0.00% (Net Income TTM 30.5m / Total Stockholder Equity 94432.86b)
RoCE = 0.00% (EBIT 56.4m / Capital Employed (Equity 94432.86b + L.T.Debt 632.3m))
RoIC = 5.26% (NOPAT 52.4m / Invested Capital 995.8m)
WACC = 0.00% (E(367.1m)/V(468328.71b) * Re(8.10%) + D(468328.34b)/V(468328.71b) * Rd(0.00%) * (1-Tc(0.07)))
Discount Rate = 8.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.65%
Fair Price DCF = unknown (Cash Flow -49.3m)
EPS Correlation: 16.42 | EPS CAGR: 5.69% | SUE: -0.14 | # QB: 0
Revenue Correlation: 47.91 | Revenue CAGR: -0.64% | SUE: -0.52 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.29 | Chg30d=-0.025 | Revisions Net=+0 | Analysts=6
EPS next Year (2026-12-31): EPS=1.15 | Chg30d=-0.065 | Revisions Net=+0 | Growth EPS=-12.2% | Growth Revenue=+0.3%
Additional Sources for SCM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle